Pioglitazone and risk of mortality in patients with type 2 diabetes: results from a European multidatabase cohort study.

Strongman, H; Korhonen, P; Williams, R; Bahmanyar, S; Hoti, F; Christopher, S; Majak, M; Kool-Houweling, L; Linder, M; Dolin, P; +1 more... Heintjes, EM; (2017) Pioglitazone and risk of mortality in patients with type 2 diabetes: results from a European multidatabase cohort study. BMJ open diabetes research & care, 5 (1). e000364. ISSN 2052-4897 DOI: https://doi.org/10.1136/bmjdrc-2016-000364

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1136/bmjdrc-2016-000364

Abstract

Share

Download

Filename: Pioglitazone and risk of_GOLD VoR.pdf

Licence: Creative Commons: Attribution 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar